Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Human Vaccines & Immunotherapeutics|February 19, 2014
Vaccination against Alzheimer disease: an update on future strategiesAntonia Fettelschoss, Franziska Zabel, Martin F BachmannCurrent Opinion in Virology|June 5, 2013
Virus-induced humoral immunity: on how B cell responses are initiatedFranziska Zabel, Thomas M Kündig, Martin F BachmannPraxis|October 12, 2014
[Transcutaneous applications for vaccination and immunotherapy]Isabel Krämer, Franziska Zabel, Thomas M Kündig, et al.Nature Communications|November 20, 2014
Semi-permeable coatings fabricated from comb-polymers efficiently protect proteins in vivoMi Liu, Pål Johansen, Franziska Zabel, et al.European Journal of Immunology|December 30, 2014
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory diseaseKiran Dallenbach, Patrik Maurer, Till Röhn, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2012
Innate immunity mediates follicular transport of particulate but not soluble protein antigenAlexander Link, Franziska Zabel, Yvonne Schnetzler, et al.Experimental Dermatology|February 1, 2013
The antihistamines clemastine and desloratadine inhibit STAT3 and c-Myc activities and induce apoptosis in cutaneous T-cell lymphoma cell linesUdo Döbbeling, Ying Waeckerle-Men, Franziska Zabel, et al.Immunology|November 19, 2016
Distinct T helper cell dependence of memory B-cell proliferation versus plasma cell differentiationFranziska Zabel, Antonia Fettelschoss, Monique Vogel, et al.Vaccine|March 24, 2010
Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodiesAndrea Jegerlehner, Melanie Wiesel, Klaus Dietmeier, et al.Plos One|November 22, 2013
Bacterially produced recombinant influenza vaccines based on virus-like particlesAndrea Jegerlehner, Franziska Zabel, Alice Langer, et al.Pageof 2